To build Serologicals’ product portfolio, Life Science Partner recruits former Amersham Biotech head of North American R&D, global genomics
Life Science Partner announces the placement of Dennis W. Harris as vice president of research and development/business development and chief scientific officer at Serologicals Corporation in Norcross, Georgia. With the move, Harris becomes the senior leader in strategic planning for overall product portfolio expansion as well as identification and development of new product opportunities. Serologicals is a global provider of products and technologies for the development and manufacture of biologically based products. The company competes in three primary areas: specialty cell culture supplements, life science reagents, and diagnostic antibodies.
“In Harris, Serologicals welcomes just the right talent for their product development efforts,” says Life Science Partner Founder and President Thomas H. Callaway. “Harris is a leader in creating integrated systems for genomics and the discovery sciences. And he’s a proven R&D manager at the global level as well.”
Throughout his 22-year career, Harris has demonstrated both a keen scientific awareness and an aptitude for successfully managing research and development projects in the molecular biology industry. In his dual role as vice president of research and development for North America and genomics at Amersham Pharmacia Biotech, for example, Harris led an organization with 220 scientists and engineers while maintaining strategic responsibility for genomics research worldwide, among other duties.
Harris comes to Serologicals most recently from Vitra Bioscience, where he served as executive vice president of research and development. At Vitra, Harris held primary responsibility for automating and integrating cellular assays with engineering software for higher throughput as well as cultivating relationships with top pharmaceutical companies.
As senior vice president for ACLARA BioSciences, a developer of technologies for gene and protein analysis, he directed the company’s R&D program and was heavily involved in strategic development. Later, Harris led system integration and business development efforts at ACLARA BioSciences, in which capacity he closed the company’s largest deal.
Harris launched his career as a development scientist with Amersham in 1982. As life sciences research program manager, based in England, he later led a team of scientists funded by the European Economic Community to develop automated systems for DNA sequencing, template preparation and related methodologies. More recently, while senior program manager at Molecular Dynamics (later acquired by Amersham), he directed the development and launch of the MegaBACE 1000 DNA Sequencing System. In this role, he provided technical and strategic direction while managing engineering, software, applications, reagent development, and marketing. He was then promoted to vice president of research and development for North America and genomics, a position he held for three years.
Harris holds a doctorate in biochemistry from the University of Sussex, Brighton, UK.